Andreas Huettmann

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Nora Liebers, Johannes Duell, Donnacha Fitzgerald et al. · Blood Advances · 2021 · 92 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003

Dieter Hoelzer, Andreas Huettmann, Felix Kaul et al. · Blood · 2010 · 83 citations

Life Sciences, Immunology, Oncology +12

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Nicola Goekbuget, Joachim Beck, Monika Brüggemann et al. · Blood · 2012 · 78 citations

Medicine, Geriatric Medicine, Oncology +14

PEG-Asparaginase Intensification In Adult Acute Lymphoblastic Leukemia (ALL): Significant Improvement of Outcome with Moderate Increase of Liver Toxicity In the German Multicenter Study Group for Adult ALL (GMALL) Study 07/2003

Nicola Goekbuget, Anja Baumann, Joachim Beck et al. · Blood · 2010 · 58 citations

Medicine, Hematology, Oncology +14

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results

Maurizio Martelli, Luca Ceriani, Giovannino Ciccone et al. · Journal of Clinical Oncology · 2024 · 28 citations · Full text

Medicine, Hematology, Oncology +16